3'-fluoro-5'-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)biphenyl-2-carbonitrile | 462652-02-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3'-fluoro-5'-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)biphenyl-2-carbonitrile
• 英文别名: 3'-Fluoro-5'-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)biphenyl-2-carbonitrile；2-[3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile
• CAS: 462652-02-4
• 化学式: C₁₉H₁₉BFNO₂
• 分子量: 323.175
• InChiKey: KUHIVVOEVYDSOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.66
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  42.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-Bromoimidazo[1,2-a]pyrimidin-7-ylmethanol 、 3'-fluoro-5'-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)biphenyl-2-carbonitrile 以to give 3′-fluoro-5′-(7-hydroxymethylimidazo[1,2-α]pyrimidin-3-yl)biphenyl-2-carbonitrile as a yellow solid的产率得到3'-Fluoro-5'-(7-hydroxymethylimidazo[1,2-alpha]pyrimidin-3-yl)biphenyl-2-carbonitrile
  参考文献：
  名称：

  Imidazo-pyrimidine derivatives as ligands for gaba receptors

  摘要：

  一类3-苯基咪唑并[1,2-α]嘧啶衍生物，取代苯环的间位，由一个可选取代的芳基或杂环芳基团直接或通过氧原子或—NH—键桥接，苯环上进一步取代了烷基，三氟甲基，烷氧基或一个或两个卤素原子，特别是氟原子，是GABAA受体的选择性配体，特别是对α2和/或α3和/或α5亚单位具有良好的亲和力，因此有助于治疗和/或预防中枢神经系统的不良症状，包括焦虑，惊厥和认知障碍。

  公开号：

  US06900215B2
• 作为产物：
  描述：

  1-溴-3-氟-5-硝基苯 在 potassium fluoride 、 tris-(dibenzylideneacetone)dipalladium(0) 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 三叔丁基膦 、 氢溴酸 、 potassium acetate 、 二甲基亚砜 、 tin(ll) chloride 、 copper(I) bromide 、 sodium nitrite 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙醇 为溶剂， 反应 46.0h， 生成 3'-fluoro-5'-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)biphenyl-2-carbonitrile
  参考文献：
  名称：

  Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABA_Aα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders

  摘要：

  A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for or the GABA(A)alpha 2 and -alpha 3 subtypes is reported. The 7-trifluoroinethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.

  DOI：

  10.1021/jm051065l

文献信息

• Imidazo-pyridine derivatives as ligands for gaba receptors
  申请人：Goodacre Charles Simon

  公开号：US20050165048A1

  公开（公告）日：2005-07-28

  A class of 8-fluoro-3-phenylimidazo[1,2-a]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group, or by a pyrrolidinonyl group, which is directly attached or bridged by an oxygen atom or by a —NH— or —OCH 2 — linkage, being selective ligands for GABA A receptors, in particular having high affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类8-氟-3-苯基咪唑[1,2-a]吡啶衍生物，取代苯环的间位的芳基或杂环基或吡咯烷基，可以是可选的取代基，或是直接通过氧原子或- NH-或-OCH2-连接桥接，是GABAA受体的选择性配体，特别是具有对其α2和/或α3和/或α5亚基高亲和力，因此有益于治疗和/或预防中枢神经系统的不良症状，包括焦虑，抽搐和认知障碍。
• (1, 8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses
  申请人：——

  公开号：US20040171633A1

  公开（公告）日：2004-09-02

  A class of [1,8] naphthyridine analogues which are substituted in the 4-position by a substituted phenyl ring. These compounds are ligands for GABA A receptors and useful in the therapy of deleterious mental states such as anxiety.

  这是一类1,8-萘啶类似物，其4位被取代的苯基环。这些化合物是GABAA受体的配体，可用于治疗焦虑等有害精神状态。
• (1,8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses
  申请人：Carling William Robert

  公开号：US06960598B2

  公开（公告）日：2005-11-01

  A class of [1,8] naphthyridine analogues which are substituted in the 4-position by a substituted phenyl ring. These compounds are ligands for GABA A receptors and useful in the therapy of deleterious mental states such as anxiety.

  一类[1,8]萘啶类似物，其4位被取代苯基环所取代。这些化合物是GABAA受体的配体，对治疗焦虑等有害精神状态有用。
• Imidazo-pyridine derivatives as ligands for GABA receptors
  申请人：Merck Sharp & Dohme Limited

  公开号：US07279580B2

  公开（公告）日：2007-10-09

  A class of 8-fluoro-3-phenylimidazo[1,2-α]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group, or by a pyrrolidinonyl group, which is directly attached or bridged by an oxygen atom or by a —NH— or —OCH2— linkage, being selective ligands for GABAA receptors, in particular having high affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类8-氟-3-苯基咪唑[1,2-α]吡啶衍生物，苯环的间位被一个可选择取代的芳基或杂环基团或一个吡咯烷基取代，该基团通过氧原子或者-NH-或-OCH2-链直接连接或桥接，是GABAA受体的选择性配体，特别是对其中的α2和/或α3和/或α5亚单位具有高亲和力。因此，这些化合物有益于治疗和/或预防中枢神经系统的不良病症，包括焦虑、惊厥和认知障碍。
• Imidazo[1,2<i>-a</i>]pyrimidines as Functionally Selective and Orally Bioavailable GABA_Aα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders
  作者：Simon C. Goodacre、Leslie J. Street、David J. Hallett、James M. Crawforth、Sarah Kelly、Andrew P. Owens、Wesley P. Blackaby、Richard T. Lewis、Joanna Stanley、Alison J. Smith、Pushpinder Ferris、Bindi Sohal、Susan M. Cook、Andrew Pike、Nicola Brown、Keith A. Wafford、George Marshall、José L. Castro、John R. Atack

  DOI：10.1021/jm051065l

  日期：2006.1.1

  A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for or the GABA(A)alpha 2 and -alpha 3 subtypes is reported. The 7-trifluoroinethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.